Related Experiment Video
Updated: Aug 9, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Predictors of chronotropic incompetence in the pacemaker patient population
1Charité-Campus Mitte, Medizinische Klinik mit Schwerpunkt Kardiologie Angiologie, Pneumologie, Schumannstrasse 20/21, D-10117 Berlin, Germany. christoph.melzer@charite.de
Insights
Chronotropic incompetence (CI) affects 51% of pacemaker patients, indicated by reduced VO2 max. Predictors include heart disease, prior surgery, and specific medications like beta-blockers.
Area of Science:
- Cardiology
- Exercise Physiology
Background:
- Chronotropic incompetence (CI) is a condition affecting heart rate response during exercise.
- Pacemaker patients often present with complex cardiac histories and comorbidities.
Purpose of the Study:
- To evaluate cardiopulmonary exercise testing (CPET) results for chronotropic incompetence (CI) in pacemaker patients.
- To identify comorbidities and antiarrhythmic medications as potential indicators of CI.
Main Methods:
- Prospective evaluation of 292 pacemaker patients undergoing CPET.
- Analysis of clinical characteristics, comorbidities, and antiarrhythmic drug use in relation to CI diagnosis.
- Application of Wilkoff's definition for CI based on exercise stress testing.
Main Results:
- 51% of the pacemaker patient cohort exhibited CI.
- Reduced maximum oxygen uptake (VO2 max) and exercise duration were observed in CI patients.
- Significant predictors of CI included coronary artery disease, acquired valvular heart disease, prior cardiac surgery, and chronic use of digitalis, beta-blockers, and amiodarone.
Conclusions:
- VO2 max, coronary artery disease, acquired valvular heart disease, previous cardiac surgery, and specific antiarrhythmic medications (digitalis, beta-blockers, amiodarone) are predictive of CI in pacemaker patients.
Aims:
We prospectively evaluated results from cardiopulmonary exercise testing for chronotropic incompetence (CI) in a cohort of 292 pacemaker patients. In addition, we evaluated comorbidity and antiarrhythmic patient data as indicators of CI.
Methods And Results:
On the basis of exercise stress testing and application of the definition of CI by Wilkoff, 51% of our cohort was categorized as having CI. Indications for pacemaker implant for this patient group were 42% atrioventricular block, 56% sinus node disease, and 59% atrial fibrillation. Maximum oxygen uptake (VO(2) max) and exercise duration were significantly reduced among CI pacemaker patients, whereas oxygen uptake at the anaerobic threshold remained unchanged. The following clinical characteristics were significant predictors of CI: existence of coronary artery disease (P = 0.038), presence of an acquired valvular heart disease (P = 0.037), and former cardiac surgery (P = 0.041). Age, gender, arterial hypertension, cardiomyopathy, congenital heart disease, left ventricular ejection fraction, and time period between stress-exercise examination and pacemaker implantation were not significant predictors of CI. Chronic antiarrhythmic therapy with digitalis (P = 0.013), beta blockers (P = 0.036), and amiodarone (P = 0.045) were significant predictors of CI. In contrast, medication with class I and IV antiarrhythmics had no significant correlation with CI.
Conclusion:
We found the following characteristics predictive of CI in this pacemaker patient population: VO(2) max, existence of coronary artery disease or acquired valvular heart disease, previous cardiac surgery, as well as medication with digitalis, beta blockers, and amiodarone.
Related Concept Videos
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Electrophysiology of Normal Cardiac Rhythm
Mechanism of Cardiac Arrhythmias
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Pathophysiology of Cardiac Performance
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

